Detection of host cell residual DNA, ddPCR has many benefits [new product recommendation]

When manufacturing therapeutic proteins, vaccines, and other biological products, pharmaceutical companies must purify active molecules from bacteria or mammalian host cells

This requires strict quality control

To this end, Bio-Rad has launched a new product-ddPCR™ Supermix for Residual DNA Quantification

Compared with real-time quantitative PCR technology, the advantage of using droplet digital PCR (ddPCR) technology and premix is ​​that the DNA purification step can be skipped and the residual DNA of the host cell can be directly determined

At the same time, ddPCR technology directly counts the number of target molecules without the need to establish a standard curve, thus greatly simplifying the quantification of residual DNA

ddPCR™ Supermix for Residual DNA Quantification is provided at a concentration of 2x.

Bio-Rad's QX200 microdroplet digital PCR system was launched two years ago

Learn about the ddPCR platform and more applications of this technology